Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

The hairless gene is crucial for hair health, and its mutations cause hair loss.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Gender and social factors, not just biology, affect COVID-19 death rates.

Follistatin and LIN28B together improve the ability of inner ear cells in mice to regenerate into hearing cells.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Transgender women can still get testicular cancer, so proper screening is important.

Hair transplantation can help transgender patients affirm their gender identity.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Testosterone increases hair growth and acne in transgender men.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.